Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Concord Drugs Financial Results

Concord Drugs Ltd reported audited consolidated net profit of ₹1.06 Crore for FY26, up from ₹0.34 Crore last year. Revenue significantly increased to ₹78.77 Crore.

Source

BSE filing, NSE: CONCORD. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Concord Drugs Ltd: key numbers

Share price
₹64.01
Market cap
₹84.33 Cr
Revenue (annual)
₹78.74 Cr
Net profit (annual)
₹1.06 Cr
P/E (TTM)
41.1×Sector 46.1×
Promoter holding
45.08%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Concord Drugs Ltd

All →

Other financial results announcements

All →